Annual Percentage rate
Big-ticket purchases such as homes or vehicles come with associated costs in the form of interest rates when taking out loans; it is, therefore, important to know the total cost that a particular option will incur. Although posted interest rates seem to make an attractive proposition for borrowing money, one must look beyond this scheme. The one term whose meaning encompasses the whole picture is known as Annual Percentage Rate or APR. Reading this article to the end will cover what APR is, how it is computed, types of APR, and real-life examples. Read on to better grasp APR and what it means to your borrowing expenses.
Table of Contents
Annual percentage rate
In the world of personal finance, both individuals and corporations frequently borrow money and use credit. It can be difficult to determine the true cost of borrowing because so many different loans and credit choices are accessible. The Annual Percentage Rate, or APR, a key idea in the financial world, enters the picture. The APR is an essential tool for comprehending the true cost of borrowing and offers consumers useful information for making wise decisions.
Annual Percentage Rate means the total cost of borrowing money on an annual basis. It incorporates interest and other associated fees into a single simple rate. The APR allows borrowers to compare loan offers from different lenders on an equal playing field because it accounts for all expenses rather than just the advertised interest rate. It shows the real yearly cost of taking out a loan, which is stated as a percentage of the original amount borrowed, which is essential for determining the true affordability of any financing option.
What is APR?
In lay terms, the annualised interest rate levied on borrowers for loans or credit cards is the APR. APR considers other expenditures like origination fees, discount points, and additional financial charges, unlike the nominal interest rate, which solely shows the interest payable on the principal amount. The APR enables borrowers to effectively compare various loan or credit offers because it indicates the entire cost of borrowing over a year.
The idea of APR could appear challenging at first, particularly when contrasted with the simpler nominal interest rate. Understanding its importance, however, can substantially impact one’s financial well-being and support prudent financial planning.
Understanding APR
A fundamental statistic that goes beneath the surface of nominal interest rates is the APR. The APR accounts for additional charges related to loans or credit cards, whereas nominal rates solely reflect the base interest imposed on borrowed money. APR gives borrowers a thorough understanding of their overall annual borrowing expenses.
Borrowers make wiser financial decisions if they know the relevance of APR. As APR makes it possible to estimate the exact cost associated with a loan or credit offer, comparing several loans or credit offers becomes easier.
Understanding APR enables people to navigate the credit world carefully, ensuring they choose the financial solutions most suited to their requirements and long-term objectives.
Working of APR
The loan amount, nominal interest rate, loan period, and additional fees are just a few variables that must be considered when calculating APR. Lenders calculate APR using a standardised method to provide uniformity and transparency throughout the borrowing process.
APR is determined using the following formula:
APR = (total interest + additional fees) / (loan amount * 100)
If you take a US$1,000 loan for a year at a nominal interest rate of 10% and pay the lender a US$50 origination fee, the APR is determined by:
Total interest: (US$1,000 * 10%) * 100 * 100 = US$100
APR: (US$100 + US$50) / 100 * 100 = 15%
Types of APRs
Various loan products have different types of Annual Percentage Rates that apply depending on their unique features. Understanding the distinctions between APR types is important when comparing loans.
- Fixed vs Variable APR
Fixed APR > An interest rate that is the same for one loan throughout the full term of the financing. This gives security in the cost. Indeed, other loans, like most credit cards, are infamous for having a kind of APR that changes over time with market conditions called variable, and it can go up as well as down. As you are aware, fixed rates also protect against the uncertainty of variable rates.
- Open-end Credit and Closed-end APRs
Credit cards and other open-ended lines of credit artifacts do not have a fixed payoff date or amount drawn. Revolving balance ARP: A closed-end loan, such as a mortgage (or auto loan), is one where the full amount borrowed is provided to you upfront, so its ARP takes only those relevant costs at that time.
- Purchases and Cash Advance APRs
Cardholders usually have to deal with APRs that differ for purchases but not cash advances. One reason behind this may be that cash advances are obtained immediately rather than having a grace period before the interest kicks in, resulting in higher APRs. To save on financing charges, cardholders must understand these two categories of APRs.
- Introductory and Standard APRs
Some credit cards offer introductory APRs for a limited term, often six months. The ending phase of such promotions is characterised by steep standard APRs. As a result, borrowers ought to compare the costs involved in such introductory offers with those of other forms.
Calculating Annual Percentage Rate
Due to this consistency, the Truth in Lending Act offers lenders standardised equations when calculating APR values. These depend on whether the financing arrangement is an open-ended or closed-end credit. In closed-ended loans-for example, auto loans or mortgages that involve a fixed amount provided at the beginning, the APR calculation is the total dollar value of all finance charges divided by the amount borrowed expressed as an annual rate percentage.
Revolving-balanced open-ended credits, such as credit cards, on the other hand, need annualization of a periodic interest rate in case fees and interest are levied on outstanding balances over time.
This provides lenders with a chance to calculate what portion of the original amount availed by the customer constitutes the total yearly cost of borrowing by putting all relevant costs, such as interest rates, fees, and terms of the loan, into the relevant formula. This provides clear visibility when comparing shopping through the APR metric.
Examples of annual percentage rate
Let us consider that you are weighing two credit card offers. For the first six months, the APR on Credit Card A is 0%; after that, it rises to 18%. Instead of an introductory deal, Credit Card B carries a constant APR of 15% from the beginning.
Since Credit Card A won’t charge interest during the promotional period, it would be preferable if you intended to pay off the balance within six months. However, Credit Card B’s lower normal APR might be more economical in the long run if you carry a balance for a considerable amount of time.
Conclusion
The Annual Percentage Rate indicates the true cost of financing, not merely interest charges, as it considers all expenses. It does this in a fair and transparent way.
Since APR is computed using specified formulas, computation consistency is ensured across lenders and products. While headline rates may focus on a single point, APR provides the complete picture of borrowings’ affordability with one broad metric.
The ability to make sound financial decisions requires looking beyond the glitter of an offer and understanding correctly the commitments one is getting into in terms of loans using their annual percentage rates.
Frequently Asked Questions
APR is computed as a percentage by multiplying the entire amount of interest and fees charged on a loan or credit by the loan amount. The formula for doing so is:
APR = (Total Interest + Additional Fees) / (Loan Amount * 100)
APR and APY differ mostly in how they are applied. APR, which stands for interest rate plus fees, is used for credit and loans. APY, which considers compound interest and reflects the real return generated, is used for savings accounts and investments.
The annual percentage rate, or APR, comprises the overall cost of borrowing, including interest and fees. In contrast, the fundamental rate before further expenses are considered is the nominal interest rate. The daily periodic rate, calculated by dividing the nominal rate by the number of days a year, is the daily interest rate.
The APR is disclosed to give borrowers a clear picture of the actual cost of borrowing. It fosters transparency and allows borrowers to efficiently compare various loan or credit offers to make wise financial decisions.
Despite being a valuable tool for comparing borrowing expenses, APR has some restrictions. Long-term forecasts might be less accurate because they might not consider variable APRs’ shifting interest rates. Additionally, compounding is not viewed by APR, which impacts savings and investments and may cause differences in actual expenses.
Related Terms
- Investment adviser public disclosure
- Price-to-Book Ratio
- Investment adviser registration depository
- Contingent deferred sales charges
- Net asset value (NAV)
- CAGR
- Mark-to-market
- Federal Open Market Committee
- FIRE
- Applicable federal rate
- Automated teller machine
- Central limit theorem
- Balanced scorecard
- Analysis of variance
- Double Taxation Agreement
- Investment adviser public disclosure
- Price-to-Book Ratio
- Investment adviser registration depository
- Contingent deferred sales charges
- Net asset value (NAV)
- CAGR
- Mark-to-market
- Federal Open Market Committee
- FIRE
- Applicable federal rate
- Automated teller machine
- Central limit theorem
- Balanced scorecard
- Analysis of variance
- Double Taxation Agreement
- Floating Rate Notes
- Average True Range (ATR)
- Constant maturity treasury
- Employee stock option
- Hysteresis
- RevPAR
- REITS
- General and administrative expenses
- OPEX
- ARPU
- WACC
- DCF
- NPL
- Capital expenditure (Capex)
- Balance of trade (BOT)
- Retail price index (RPI)
- Unit investment trust (UIT)
- SPAC
- GAAP
- GDPR
- GATT
- Irrevocable Trust
- Line of credit
- Coefficient of Variation (CV)
- Creative Destruction (CD)
- Letter of credits (LC)
- Statement of additional information
- Year to date
- Certificate of deposit
- Price-to-earnings (P/E) ratio
- Individual retirement account (IRA)
- Quantitative easing
- Yield to maturity
- Rights of accumulation (ROA)
- Letter of Intent
- Return on Invested Capital (ROIC)
- Return on Equity (ROE)
- Return on Assets (ROA)
Most Popular Terms
Other Terms
- Donchian Channels
- Dollar Smile Theory
- Dividend Clawback
- Dividend Payout Ratio
- Defensive Sectors
- Dark Pool Liquidity
- Crypto Asset Management
- Yield Maintenance
- Warrant Coverage
- Variable Annuity
- Asset Swaps
- Anchoring Bias
- Alpha Capture
- Bond Convexity
- Compound Yield
- Brokerage Account
- Discretionary Accounts
- Industry Groups
- Growth Rate
- Green Bond Principles
- Gamma Scalping
- Funding Ratio
- Free-Float Methodology
- Foreign Direct Investment (FDI)
- Floating Dividend Rate
- Flight to Quality
- Real Return
- Protective Put
- Perpetual Bond
- Option Adjusted Spread (OAS)
- Non-Diversifiable Risk
- Merger Arbitrage
- Liability-Driven Investment (LDI)
- Income Bonds
- Guaranteed Investment Contract (GIC)
- Flash Crash
- Equity Carve-Outs
- Cost of Equity
- Cost Basis
- Deferred Annuity
- Cash-on-Cash Return
- Earning Surprise
- Capital Adequacy Ratio (CAR)
- Bubble
- Beta Risk
- Bear Spread
- Asset Play
- Accrued Market Discount
- Ladder Strategy
- Junk Status
Know More about
Tools/Educational Resources
Markets Offered by POEMS
Read the Latest Market Journal
Halyk Bank: Balancing Yield And Growth
Investment Overview Kazakhstan's largest bank by assets, Halyk Bank (KASE: HSBK), offers an attractive dividend yield, but slowing earnings growth and rising credit risks raise questions about the sustainability of future payouts. Price/book compares the share price with the bank's net worth per share. Net interest margin is what the bank keeps from lending after paying for deposits. Return on equity is the profit earned on shareholders' money. Still Earning Over KZT 200 Billion A Quarter, After A Record 2025 Quarterly Net Income, KZT Billion Q1 2025 to Q2 2026 are actual results. The Q3 and Q4 2026 bars are an illustration, not an analyst forecast. The orange line is management's ~KZT 1 trillion target for 2026 spread evenly across four quarters. Source: JSC Halyk Bank, Interim Condensed Consolidated Financial Information for the Six Months Ended 30 June 2026 (Unaudited). Why It Is Interesting• Number one in Kazakhstan by assets, loans, deposits and net income (40.2% of sector profit in Q2).• High dividend: 2026 payouts of KZT 58.19 per share represent approximately 15.7% of the price, and about 60% of 2025 profit was distributed.• Strong capital cushion: 19.0% core capital ratio vs a 9.5% minimum, though it fell from 21.0% in March after dividend payments.• Lending recovered in Q2 (net loans +4.0% on the quarter), and the stock trades near 1.1x book.• Growing economy: Kazakhstan's GDP rose 4.2% in January-September 2026, led by non-resource sectors, and system-wide loans are up about 14% and deposits 17% on a year ago.• Large customer base: 8.6 million monthly super-app users, and active Halyk salary cards equal about 39% of Kazakhstan's employed population. Be Careful• Profit is falling: 1H net income down 15.3%, and Q2 was the lowest in two years.• Regulation is squeezing margins: higher central-bank reserve requirements cut the net interest margin to 6.8% from 7.3%, and tighter retail-lending rules have hurt fees.• Bad loans are rising: loans overdue by more than 90+ days increased to 5.3% of total loans (up from 4.3% at year-end, 3.0% a year ago), and loan-loss charges rose 69%.• The yield looks high partly because 2025 was a record profit year.• Trading is thin, and a controlling shareholder holds most of the stock. Who It May Suit: Dividend-seeking investors who are comfortable with frontier market risks, including profit volatility, share price swings, and lower liquidity. If you hold it, keep it to a small slice of your portfolio. Halyk Bank: The Details What It Does Halyk is the country's largest bank, with KZT 22.0 trillion of assets. About 82% of its income comes from lending, with the rest from foreign-exchange and securities gains (11%), fees (7%) and insurance and other (about 1%). It has three customer businesses: retail banking (B2C, 34% of loans), SME banking (17%) and corporate banking (48.5%), with SME and corporate together forming its B2B arm. The bank also offers insurance, brokerage and leasing services, and has operations in Georgia and Uzbekistan. What Changed In 1H 2026, And Why It Matters What Happened Why It Matters Profit fell 15%. Net income was KZT 447.6B vs KZT 528.6B a year ago, and Q2 (KZT 212.8B) was the lowest in two years. Profit funds dividends and supports the share price, so the trend matters more than any single quarter. Funding costs rose faster than income. Interest earned grew 12%, but interest paid grew 22% (deposit rates rose about 10% vs 8.7%), so core lending profit grew only 2.6%. Like a shop whose costs rise faster than its prices. Four central-bank rate cuts since June (with the policy rate reduced to 15.75% on 23 October) should gradually ease deposit costs. Banks must hold more money in reserve. Margin fell to 6.8% from 7.3% (about 7.2% without the rule change, says the company). Reserve funds generate little income. This is a regulatory squeeze rather than a pricing problem, but regulations can change again. More set aside for bad loans. Charges rose 69% to KZT 104B, and loans overdue 90+ days are 5.3% of loans (3.0% a year ago; 9.2% in retail). Households are finding it harder to repay, and money set aside cannot be paid out as dividends. Side businesses went backwards. Insurance swung to a KZT 6.1B loss (from KZT 25.8B profit), and fees fell 19.6% (company cites buy-now-pay-later rules and VAT). These businesses cushioned 2025 profit. Now the bank leans harder on lending, which is under pressure. Management's 2026 Guidance VS 1H Actuals Metric FY26 Guidance 1H 2026 Actual Our Read Net Income ~KZT 1T KZT 447.6B Behind: Needs ~KZT 276B a quarter in 2H, vs KZT 213B in Q2 Return On Equity ~29% 24.8% Behind Loan Growth 9-12% 1.2% year to date Behind Fee Income -10% (Cut from +5-10%) -19.6% Behind Margin / Bad-Loan Charges / Costs vs Income ~6.8% / ~1.5% / 18-20% 6.8% / 1.4% / 19.2% In line Dividends: How Sustainable Is The Yield? Halyk paid KZT 58.19 per share for 2025 (KZT 30.10 in May, KZT 28.09 in September), about 60% of 2025 profit, in line with recent years and above the 50% minimum in its stated policy. But the yield looks backwards: it reflects a record 2025 profit (KZT 1.06T), the September payment came from earnings kept in earlier years, and the capital ratio fell from 21.0% to 19.0% after the May payout. The next payout depends on 2026 profit, which is falling. Here is a scenario analysis: 2026 Net Income Dividend Per Share At 50% / 60% Payout Yield At KZT 370.10 (50% / 60%) KZT 1.0T (Guidance) KZT 46 / KZT 55 12.4% / 14.9% KZT 0.9T (About The 1H Pace) KZT 41 / KZT 50 11.2% / 13.4% KZT 0.8T (Further Slowdown) KZT 37 / KZT 44 9.9% / 11.9% Scenario analysis, not a forecast: it assumes about 10.9 billion shares and is before tax. Bottom Line: Unless profit recovers to management's target and the payout stays near 60%, dividend yield is expected to be lower than the ~15.44% recorded as at 10 November 2026; at the 1H pace it would be about 11-13%. Profit funds dividends, and hence it can vary. Where It Trades Halyk Bank is now offered on POEMS, with settlement in USD or SGD. It is listed on KASE (HSBK) and as GDRs in London (HSBK, one GDR = 40 shares). Average daily trading value is KZT 239.85 million (about US$0.53 million), which is small next to larger markets, so buying and selling can be harder than usual. Key Risks Bad Loans: Stage 3 loans (credit-impaired or are in default under the IFRS 9) are 8.6% of loans (vs. 6.6% a year ago), with coverage down to 58% from 73%. Economy And Currency: One bank in one economy, exposed to inflation, rates and the tenge (which also moves SGD returns). Regulations can change again. Control And Liquidity: ALMEX holds roughly 62% of the shares and Bank of New York (GDR nominee) about 35%, meaning only a small portion of the stock is available for trading, which can reduce liquidity. Growth Backdrop And What To Watch A growing economy supports loan demand and deposits. GDP grew 4.2% in January–September 2026, led by construction, manufacturing, transport and trade, and inflation has eased enough for the central bank to cut rates. Watch: Q3 results (expected mid-November 2026), loan growth, overdue loans, margin and the tenge. Trade Kazakhstan With POEMS Kazakhstan-listed shares are now available for online trading through POEMS. Trading Hours (SGT) Pre-Opening Session 2:20PM – 2:30PM Main Continuous Session 2:30PM – 8:30PM For more information, visit POEMS or contact our Global Markets Desk at talktoglobalmarkets@phillip.com.sg. Make Kazakhstan Part Of Your Global Market View Explore Kazakhstan on POEMS and discover opportunities across KASE. Trade Kazakhstan ↗ Open An Account Now! Sources JSC Halyk Bank, Interim Condensed Consolidated Financial Information for the Six Months Ended 30 June 2026 (Unaudited) https://halykbank.com/storage/830/Press-Release.pdf Halyk Group, 1H and 2Q 2026 Results Presentation (August 2026) https://halykbank.com/storage/831/Presentation.pdf Market data: Bloomberg, 28 Oct 2026; US$ at about KZT 452 Q3/Q4 2025 profit: Halyk Bank financial statements https://halykbank.com/storage/259/Financial-Statement.pdf https://halykbank.com/storage/700/Financial-Statement.pdf Dividend and shareholding details: Bloomberg GDP, loan and deposit data: Kazakh government and National Bank, Oct 2026 https://www.bis.org/speeches/20261021-results-socio-economic-development-and-execution-republican-budget-january-september-2026 Scenario analysis and income splits are our own calculations; the Q3 results date is an estimate. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Oracle Corp: BUY Maintained with Target Price of US$225 as Positive Free Cash Flow Comes into Sight
Brief Overview Oracle held its Investor Day on 28 October 2026 as part of AI World in Las Vegas, outlining a path to positive free cash flow (FCF) from FY29e. The company targets 10GW of data centre capacity by end-FY28, with FCF expected to turn positive in the second half of FY28 as the infrastructure build-out matures. Phillip Securities Research maintains a BUY recommendation with an unchanged target price of US$225, retaining FY27-31e estimates. We forecast US$255 billion in FY31e revenue, representing a 30% five-year compound annual growth rate (CAGR), driven by Oracle Cloud Infrastructure (OCI) capacity deployment and conversion of the US$664 billion remaining performance obligation (RPO). Investment Positives Positive Free Cash Flow from FY29e Management expects FCF to turn positive in the second half of FY28e, with Oracle becoming self-funded from FY29e as peak FY27-28 capital expenditure eases. We forecast US$4 billion in FCF for FY29e. The inflection follows the major infrastructure build-out, with Oracle targeting 10GW by end-FY28 (May 2028), including over 7GW of incremental capacity from an estimated current base nearing 3GW (a total of 1.2GW by end-FY26, 850MW in 1Q27, and the remainder in the current quarter). Alternative Financing Easing Cash Requirements Vendor financing, customer prepayments, and bring-your-own-hardware (BYOH) arrangements could reduce upfront cash needs by approximately 50%, limiting Oracle's additional external funding requirement through FY30 to US$20 billion. By way of illustration, vendor financing reduces the first-two-year capital requirement for a 1GW project from US$37 billion to US$18 billion, while BYOH could lower the requirement further to US$6 billion or less per GW, albeit at lower reported revenue but with higher margins and return on investment. Improving Revenue Per GW Oracle's revenue per GW remains below Microsoft's, but the gap should narrow through FY28-30e as new capacity ramps and the US$664 billion RPO converts into revenue. Despite a much smaller cloud revenue base, Oracle has a similarly sized backlog, offering greater catch-up potential if capacity is delivered and monetised as planned. As capital expenditure eases after FY28, higher revenue per GW translates into stronger FCF and improved infrastructure economics. We forecast a 55% increase in revenue per GW to US$17.5 billion in FY30e. Spreading Deployment Risk Oracle is reducing reliance on any single site or geography, with less than half of its eventual 10GW capacity in gigawatt-scale sites and the rest in smaller data centres globally. The 850MW delivered in 1Q27 was spread across 38 projects in 11 countries. OCI's capacity fungibility helps mitigate utilisation risk — a 512-GPU cluster (64 nodes by 8 NVIDIA/AMD GPUs) can serve up to 32 customers, with capacity reallocated between customers within hours, achieving 98% GPU utilisation in 1Q27. Oracle is also diversifying accelerator availability across NVIDIA, AMD, Google TPU and other architectures rather than tying OCI exclusively to one compute architecture. Monetising AI in Applications Oracle is adding usage-based billing for AI consumption alongside SaaS subscriptions, creating growth beyond seat additions. Embedded AI agents should automate more ERP workflows rather than displace ERP, with fewer manual workflows and less traditional user interface interaction. Fusion, Oracle's enterprise application suite, grew 14% year-on-year in 1Q27, faster than Cloud Applications at 10%. Use cases include automating finance ledger reconciliation and checking HR overtime discrepancies. Adoption is already meaningful, with 500 billion tokens consumed in September 2026 (up 23% month-on-month) and over 150 million embedded Fusion AI uses in 1Q27, though monetisation remains early as the pricing model was introduced only months ago. Strong Revenue and Backlog We expect US$255 billion in group revenue by FY31e, representing a 30% five-year CAGR, driven by OCI deployment and OpenAI backlog conversion. Over 90% of the US$664 billion RPO is tied to infrastructure. Customer concentration is declining, with over 1,000 OCI AI infrastructure customers now diversifying the backlog. Investment Challenges Temporary Margin Pressure We expect near-term adjusted operating margin dilution from 43% in FY26 to 37% in FY28e, below historical levels. The pressure reflects the growing mix of lower-margin OCI, where AI infrastructure projects generate 35% gross margin and 34% operating margin, compared with the higher-margin SaaS and database businesses. Early-Stage AI Monetisation While AI adoption is scaling rapidly within Oracle's application suite, monetisation remains early. The usage-based pricing model for AI consumption was introduced only months ago, and the extent to which it will contribute meaningfully to revenue in the near term remains to be seen. Outlook Margins should recover to approximately 40% by FY30 as data centres ramp up and capital expenditure eases. We forecast US$26.10 adjusted EPS in FY31e, implying a 27% five-year CAGR. The path to positive FCF from FY29e, combined with alternative financing structures that reduce upfront cash requirements by about 50%, supports the thesis that Oracle can achieve self-funded growth from FY29 onwards. Revenue diversification through a broadening customer base of over 1,000 OCI AI infrastructure customers should further strengthen the outlook. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Oracle Corp with an unchanged target price of US$225. FY27-31e estimates are maintained. The conviction is underpinned by the anticipated path to positive FCF from FY29e, the US$664 billion RPO providing revenue visibility, and improving infrastructure economics as capacity scales. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Brief Overview Nanofilm Technologies International Limited released its third-quarter 2026 update with limited financials. Nine-month 2026 revenue and gross profit came in within expectations, at 70 per cent and 74 per cent of Phillip Securities Research's full-year 2026 forecasts respectively. Third-quarter revenue rose 3 per cent year-on-year to S$74 million, though a 19 per cent decline in the Advanced Material – Consumer (AMC) segment was offset by strong performances in Nanofabrication and Industrial Equipment. Phillip Securities Research maintains a BUY recommendation with an unchanged target price of S$1.20. Investment Positives Growth in Industrial, Automotive, and Semiconductor Segments Nanofilm's industrial-facing segments delivered robust results in the third quarter. Advanced Material – Industrial (AMI) revenue increased 8 per cent year-on-year to S$16 million, propelled by decorative and functional coatings for metal machining and medical applications in Europe. This steady expansion in industrial coatings underscores the company's ability to grow beyond its consumer electronics core. The Industrial Equipment segment (IEBU) was a standout performer, with revenue surging 66 per cent year-on-year to S$7 million. This growth was driven by the delivery of new orders of advanced printed circuit board (PCB) drill bit equipment, a product line that is becoming an increasingly meaningful contributor to the revenue base. Strong Nanofabrication Performance The Nanofabrication segment (NFBU) recorded a remarkable 120 per cent year-on-year gain in third-quarter revenue, reaching S$12 million. The primary driver was a new health sensor programme in smartwatches. This substantial increase helped offset weakness in the consumer segment and highlights Nanofilm's success in securing new technology applications. Margin Expansion Underway Third-quarter gross margins expanded by 5 percentage points year-on-year to 45 per cent, marking the highest level since the 2022 financial year. The margin improvement was underpinned by ongoing cost optimisation efforts and the commercialisation of new programmes in PCB drill bit equipment. This trajectory suggests that Nanofilm's operational efficiency is gaining traction as newer, higher-margin revenue streams scale up. Revenue Diversification Reducing Concentration Risk A notable positive from the quarter is the declining share of revenue attributable to the AMC segment, which fell to 53 per cent in the third quarter of 2026 from 67 per cent in the same period a year earlier. This diversification away from reliance on key customer Z lowers Nanofilm's concentration risk and positions the company on a more balanced footing. Investment Challenges Consumer Segment Declines The primary headwind in the quarter came from the AMC segment, where revenue dropped 19 per cent year-on-year to S$39 million. The decline was attributed to delays in key customer Z's flagship programme and substrate changes. While the flagship programme reached full capacity in late third-quarter 2026 and is expected to support fourth-quarter growth, the near-term impact on the consumer segment was material. However, we noted that the decline in AMC revenue was partially offset by the 120 per cent year-on-year gain in NFBU revenue, driven by the health sensor programme. This suggests that while the consumer segment faces temporary pressure, other parts of the business are compensating. Outlook Phillip Securities Research expects Nanofilm's flagship smartphone programme to support fourth-quarter 2026 revenue growth, as the programme has reached full-capacity production. Customer Z has also raised its production targets, which should underpin volume growth heading into the 2027 financial year. We do not expect the recent screen issues to have a material impact on Nanofilm. Margins are expected to improve in the 2026 and 2027 financial years, supported by operating leverage from higher utilisation rates. Looking further ahead, growth in the 2027 financial year is expected to be driven by PCB drill bit equipment, functional hinge coatings for smartphones, and coatings in semiconductors, including wafer lapping carriers and anti-static discharge (ASD) applications. These growth avenues, combined with the ongoing revenue diversification, are expected to reduce reliance on any single customer or segment. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Nanofilm Technologies International Limited with an unchanged target price of S$1.20. The full-year 2026 revenue and net profit after minority interest forecasts remain unchanged. Our conviction is supported by the expectation that the flagship smartphone programme, PCB drill bit equipment, and semiconductor coatings will be the key growth drivers in the coming financial year. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Elite UK REIT: Lower Property Expenses Lift Income as BUY Maintained with Target Price of £0.40
Brief Overview Elite UK REIT reported a 7.1% year-on-year rise in 3Q26 distributable income, mainly attributable to lower property expenses which fell 47.4% to £0.47 million. The Peel Park data centre sale is on track for a 1H27 launch, with planning approval and a 120 MVA power allocation already secured for the site, valued at £44.0 million as at February 2026. Phillip Securities Research maintains a BUY recommendation with a lower DDM-based target price of £0.40, down from £0.41 previously, after increasing its cost of equity by 25 basis points to reflect a higher interest rate environment. Elite UK REIT is trading at a 9.6% FY26e dividend yield and a P/NAV of 0.68x. Investment Positives Strong Operational Performance The REIT delivered solid operational results in the third quarter of 2026. Distributable income rose 7.1% year-on-year, driven principally by a 47.4% decline in property expenses to £0.47 million. Net property income (NPI) increased 5.3% year-on-year to £9.2 million, with the NPI margin expanding 4.4 percentage points to 95.2%. We believe a full-quarter contribution from recently acquired properties will support 4Q26 results, though this will be partly offset by higher interest costs and borrowings. Progress on Value-Add Initiatives Elite UK REIT is advancing its key strategic initiatives. Peel Park has received planning consent for the development of a data centre. Management plans to launch the sale of the Peel Park site in 1H27, once National Grid confirms it can transmit power to the local network. Management sees low risk of opposition, given the site's modest scale and support from Blackpool Council. The site also has backup power options, including renewables, battery storage and an on-site gas main. The analyst believes the Department for Work and Pensions (DWP), which occupies the adjacent building, may need the property beyond its 2028 lease expiry, which could provide continued rental income alongside the sale. Separately, major strip-out works are complete at Lindsay House in Dundee, a 170-bed property. The next step is conversion into purpose-built student accommodation (PBSA). The targeted completion for Lindsay House is by June 2027, so it will be operational by September 2027. PBSA Development Potential at Glasgow Benefits Centre One of the larger assets that DWP may not renew is Glasgow Benefits Centre, valued at £4.35 million as of February 2026. It has strong potential for PBSA development, as it is situated near Glasgow Caledonian University. A nomination agreement could provide more predictable rental income. Investment Challenges Hedging Cover Reduced The share of fixed-rate borrowings has fallen to 80% as of September 2026, down from 99% in June 2026. Drawn revolving credit facility (RCF) borrowings rose by £21.1 million in 3Q26 to part-fund acquisitions, distribution payments and conversion works. Management guided that a 100-basis-point rise in floating rates would reduce DPU by 2.0%. However, Elite typically uses rent collected in advance to repay its RCF, so the analyst does not expect this to be a major concern. Outlook DWP is looking to exit more backend service and support centres such as Holborn House (Derby), Beech House (Hyde) and Cotswold House (Torquay). Management guides a renewal rate of 85% or more on the approximately 30% of leases expiring in April 2028, implying a base case of 10–15% vacancy. Built-to-rent or PBSA optionality on vacated assets offers upside. On capital management, the priority is refinancing the 2027 debt maturity rather than raising funds, and there are no near-term acquisitions. Management guided the cost of debt to hold at 4.7% this year, with at least 50% of borrowings hedged until October 2027. Recommendation and Target Price Phillip Securities Research maintains a BUY recommendation on Elite UK REIT. The DDM-based target price has been lowered to £0.40, from £0.41 previously, reflecting a 25-basis-point increase in the cost of equity to account for a higher interest rate environment. Elite UK REIT trades in GBP under the MXNU ticker and in SGD under the MENU ticker. This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Frequently Asked Questions [market_journal_faq] Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
UltraGreen.ai: BUY Maintained With Lower Target Price of US$0.73 — Segmenting to Defend
Brief Overview UltraGreen.ai, a Singapore-listed healthcare company focused on indocyanine green (ICG) products and imaging solutions, reported a robust set of results for the third quarter and first nine months of the 2026 financial year. Third-quarter revenue, net of discontinued operations, rose 43.9 per cent year-on-year to US$44.6 million, while nine-month revenue climbed 35 per cent year-on-year to US$131.8 million, forming 25 per cent of Phillip Securities Research's full-year 2026 forecast. Growth was underpinned by both the US and rest-of-world (RoW) markets. In a notable strategic move, UltraGreen relaunched its lower-priced generic ICG — functioning as an authorised generic — in late September/early October to compete with Zydus. The company did not disclose its pricing, and withheld vial volumes and average selling prices (ASPs) by region, citing commercial sensitivity. US hospitals now have three categories of ICG to choose from: UltraGreen's branded IC-GREEN; generic copies of IC-GREEN, namely UltraGreen's own authorised generic and Zydus's generic; and separately approved competing brands, including Stryker's SPY AGENT GREEN and Sagent/Provepharm's ready-to-use Zyogreen. Investment Positives Strong Financial Performance Third-quarter and nine-month revenue grew 43.9 per cent and 35 per cent year-on-year to US$44.6 million and US$131.8 million, respectively. US revenue grew 35 per cent year-on-year to US$101.3 million, while RoW revenue grew 36 per cent year-on-year to US$30.5 million. We expect further vial uptake in Europe, Australia, and Switzerland to support continued RoW momentum. Expanding Regulatory Footprint UltraGreen's Verdye was approved in South Africa, a market with approximately 3.3 million relevant procedures per year, where UltraGreen is the first approved ICG provider. This expanded IC-GREEN/Verdye approvals to forty-two countries. Additionally, IC-GREEN received US FDA orphan drug designation for liver cancer imaging, which could carry seven years of US market exclusivity upon approval — a potentially significant competitive moat. Investment Challenges Sequential Decline in Rest-of-World Revenue RoW revenue fell 18 per cent quarter-on-quarter to US$9.4 million, from US$11.4 million in the second quarter, although it was still up 32 per cent year-on-year. Management attributed the decline to a large distributor order in June that artificially boosted second-quarter figures, as well as seasonally weaker demand in July. No deterioration was evident at the customer level. Outlook For UltraGreen, the launch of the authorised generic should materially reduce what Zydus earns from its exclusivity window. Hospitals may favour UltraGreen's generic over other entrants because the authorised generic is chemically similar to IC-GREEN. Outside the US, the medium-term opportunity rests on wider ICG use and on commercialising the camera-and-software platform beyond operating theatres to outpatient clinics. Management indicated camera bundles and leases tied to ICG supply, and software sold both standalone and as camera-integrated applications. However, we believe traction will be uncertain. Recommendation and Target Price Phillip Securities Research maintains its BUY recommendation on UltraGreen.ai with a lower discounted cash flow-based target price of US$0.72, down from US$1.81 previously. The revised assumptions include: UltraGreen's US market share (branded IC-GREEN plus its own authorised generic) falling from 83 per cent to approximately 50 per cent, reducing US vials sold by 40 per cent; US vials splitting evenly between branded IC-GREEN and its own generic; the blended US ASP (branded and generic) falling approximately 40 per cent from the 2025 ASP; and vial volume growth outside the US remaining unchanged at 15 per cent a year, as RoW growth is enabled by UltraGreen's low-cost imaging cameras, which generic-only competitors do not offer. As a result, FY26 and FY27 estimated PATMIs are reduced by 6 per cent and 58 per cent, respectively. UltraGreen.ai is currently trading at a FY27 estimated price-to-earnings ratio of 13.1 times. We view these assumptions as conservative because no expansion is assumed for the overall US ICG market, and the price and volume declines are benchmarked to a US Federal Trade Commission study of oral tablets and capsules, which typically attract more competitors and experience faster price erosion than sterile injectables such as ICG. Key factors to watch include progress on PerfusionWorks' US FDA approval and the RoW vial adoption. This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Frequently Asked Questions [market_journal_faq] Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
First REIT: Accumulate With a Lower Target Price of S$0.17 — Still Waiting for the Next Move
Brief Overview First REIT reported third-quarter 2026 and nine-month 2026 distribution per unit (DPU) of 0.46 and 1.44 Singapore cents, respectively, representing declines of 11.5% and 12.7% year on year. The results came in slightly below Phillip Securities Research estimates, forming 23% and 73% of the full-year 2026 forecast. The decline was driven by the depreciation of the Indonesian rupiah (down 8% year on year over nine months) and the Japanese yen (down 9.8% year on year over nine months) against the Singapore dollar, combined with the impact of its Indonesian hospital divestments. Nine-month 2026 rental income and net property income declined by 9.5% year on year. Excluding the divestments, rental income would have declined by 6% year on year. The REIT completed the first tranche of its Indonesian hospital divestments on 24 September 2026. The potential divestment of the remaining six Indonesian hospitals to Siloam for approximately S$294.8 million under the existing put option remains under consideration. Phillip Securities Research maintains an Accumulate recommendation with a lower target price of S$0.17, reduced from S$0.23 previously, pending capital redeployment into replacement assets. The valuation is based on 0.8 times third-quarter 2026 price-to-net asset value (P/NAV), reflecting ongoing foreign exchange risks and uncertainty over the future portfolio composition. DPU forecasts have been lowered by 6% for FY26e and 38% for FY27e to reflect the first tranche of Indonesian divestments, while incorporating S$9.7 million in special dividends split evenly between the fourth quarter of 2026 and the first quarter of 2027. Including special dividends, the FY26e dividend yield is 10.2%, declining to 6.9% in FY27e following the divestments. The strategic review remains ongoing, and management has provided no updates on potential acquisitions. Investment Positives Resilient Income in Local Currency Terms Despite the headline decline in DPU, First REIT's underlying income remained resilient when measured in local currency terms. Nine-month 2026 revenue from the Indonesian properties increased by 2.8% year on year in local currency, while Singapore properties recorded a 2% increase year on year. Revenue from the Japanese properties remained stable over the same period. A further positive development was the extension of master lease agreements for two Singapore nursing homes. In August 2026, the master lease agreements for Precious Homes at Bukit Merah and Precious Homes at Bukit Panjang were extended to April 2032 and May 2033, respectively. Importantly, the 2% annual rental escalations embedded in these leases have been retained, providing income visibility and inflation protection over the extended lease terms. Investment Challenges Significant DPU Decline Expected Pending Capital Redeployment The most pressing challenge facing First REIT is the expected sharp decline in DPU following the divestment of its Indonesian properties. With the 11 divested Indonesian properties no longer contributing to earnings, Phillip Securities Research expects FY27e DPU to plunge to 1.24 Singapore cents, representing a decline of 33% year on year. This figure includes the second half of the S$9.7 million special distribution to be paid in the first quarter of 2027. Until the REIT successfully redeploys its capital into replacement assets, earnings will remain significantly diminished. Outlook The divestment proceeds have been used to fund debt repayment, resulting in a significant reduction in aggregate leverage from 42.1% to 27.5% in the third quarter of 2026. Leverage is expected to fall further to 15.6% following the redemption of its S$100 million 3.25% Guaranteed Bonds due in 2027. The all-in cost of debt improved by 10 basis points quarter on quarter to 3.9%, with 75.7% of debt fixed or hedged. However, looking ahead, we note that redeploying capital into replacement assets in developed markets may prove challenging amid rising interest rates. The pivot away from Indonesia is also likely to weigh on yields, given the difficulty of finding assets in developed markets that offer comparable returns to its former Indonesian portfolio. The strategic review remains ongoing, and management has provided no updates on potential acquisitions. Recommendation and Target Price Phillip Securities Research maintains an Accumulate recommendation on First REIT with a lower target price of S$0.17, reduced from S$0.23 previously. The target price is based on 0.8 times third-quarter 2026 P/NAV, reflecting ongoing foreign exchange risks and uncertainty over the future portfolio composition. This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Frequently Asked Questions [market_journal_faq] Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Tesla Q3 2026 Results: Margin Recovery and SELL Rating Outlook
Overview Tesla reported third-quarter 2026 results above expectations, with nine-month revenue and adjusted net profit after minority interests at 82% and 84% of full-year 2026 estimates. Adjusted net profit, excluding share-based compensation and fair value changes on bitcoin and SpaceX shares, fell 4% year-on-year to US$1.7 billion, as a 39% rise in operating expenses and a 73% fall in regulatory credits offset a 9% rise in gross profit. Revenue was flat year-on-year at US$28.0 billion. Deliveries fell 2% year-on-year to 487,000 units against a third-quarter 2025 base lifted by buying ahead of the US electric vehicle tax credit expiry, but beat consensus of 462,000. Active Full Self-Driving subscriptions rose 67% year-on-year to 1.74 million, while free cash flow fell 62% year-on-year to US$1.5 billion as capital expenditure more than doubled to US$4.7 billion. Investment Positives Margins Recover on Vehicle Mix, Energy and Services Gross margin rose 1.6 percentage points year-on-year to 19.6%. Auto gross margin excluding credits improved to 18.1% from 15.4% in the third quarter of 2025, driven by a higher Asia-Pacific delivery mix, as Model Y set delivery records in several markets including Australia, Japan and Taiwan. Energy gross margin rose to 33.1% from 31.4%, supported by tariff refunds and a vendor reimbursement of cell warranty costs. The Services and Other segment delivered strong performance, with revenue rising 33% year-on-year to US$4.6 billion and record gross profit of US$734 million at a 15.9% margin, led by Supercharging and insurance. Tesla exited the quarter with its largest order backlog in four years, and Megapacks are almost sold out for 2027. FSD and Robotaxi Are Scaling Active Full Self-Driving (FSD) subscriptions rose 67% year-on-year to 1.74 million, with half of those on monthly subscriptions, and over 75% of North America deliveries signed up for paid FSD at delivery. The chief financial officer agreed that FSD annual recurring revenue is approaching US$1 billion. FSD is approved in nine European countries, and management expects approval across the EU by the first quarter of 2027. Cybercab rides started in Austin on 3 September, cumulative unsupervised miles rose eightfold in the quarter, and Robotaxi launches in Dallas next month. Semi started volume production in Nevada, and Optimus started early production on the Fremont high-volume line. Investment Challenges OPEX Growth Absorbs the Margin Gains Operating income fell 56% year-on-year to US$718 million, and the operating margin fell to 2.6% from 5.8% in the third quarter of 2025. Operating expenses rose 39% year-on-year to US$4.8 billion, as research and development increased 69% to US$2.8 billion on SI compute depreciation, chip development and ramp costs for Optimus, Megapack 3 and Semi. Share-based compensation rose 76% to US$1.2 billion on the 2025 CEO Performance Award. Management expects operating expenses to keep rising until these products are commercialised. Regulatory credits fell 73% year-on-year to US$113 million, and GAAP net profit fell 43% year-on-year to US$787 million. Auto and Energy Revenue Fell Auto revenue fell 3% year-on-year to US$20.6 billion on lower average selling prices, lower regulatory credits and 2% fewer deliveries, as deliveries of other models fell 48% year-on-year. Energy revenue fell 16% year-on-year to US$2.9 billion, partly due to tariff-related customer refunds, and storage deployments of 13.7 gigawatt-hours, up 10% year-on-year, missed consensus of 15.9 gigawatt-hours. The energy margin was lifted by tariff refunds received and a warranty reimbursement, which may not recur. Free cash flow fell 62% year-on-year to US$1.5 billion as capital expenditure more than doubled to US$4.7 billion. Higher commodity costs and interest rates add further cost pressure. Outlook Full-year 2026 capital expenditure guidance was cut to approximately US$20 billion from over US$25 billion previously and will be funded mainly from operating cash flow, with no draws planned this year on the new US$30 billion debt facilities. However, management expects capital expenditure to rise over the next few years on the Robotaxi fleet, Optimus capacity, solar manufacturing, SI compute and the Terafab chip plant, which needs tens of billions by early 2028 and possibly over US$100 billion in the long term. Optimus should take at least a year to reach 20,000 units a week, with external deliveries from the end of 2027. Unsupervised FSD in customer cars is expected around the second quarter of 2027, and Tesla targets 5 million vehicles a year by around 2030. We note that the third quarter of 2026 was better on margins but not on profit. While gross margin recovered to 19.6% on vehicle mix, energy refunds and services, the 39% rise in operating expenses absorbed the gain, and operating margin of 2.6% is less than half of the third-quarter 2025 level. Part of the energy margin gain came from tariff refunds and a warranty reimbursement that may not recur. We remain cautious in the near term due to margin compression from rising operating expenses and fading regulatory credits, intense competition in China from BYD and domestic EV brands such as Xiaomi and Geely, elevated capital expenditure requirements, and the fact that meaningful revenue from Robotaxi and Optimus is still more than five years away. At 248 times financial year 2026 estimated price-to-earnings, the analyst believes optionality is already priced in. Recommendation and Target Price Phillip Securities Research maintains a SELL recommendation on Tesla with a higher target price of US$230, raised from US$220 previously. The increase reflects an 8% raise in financial year 2026 earnings estimates from higher auto revenue estimates. The weighted average cost of capital and growth rate assumptions of 9% and 5% respectively remain unchanged. *This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.* Frequently Asked Questions [market_journal_faq] Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Brief Overview In Sep 2026, the Singapore aviation sector continued its decline. China Aviation Oil (CAO) dropped significantly by 7.5%, followed by SATS and SIA at negative 2.3% and negative 0.7% respectively, while SIA Engineering edged up incrementally by 1.0%. Passenger growth remains under pressure from elevated jet fuel prices. However, cargo has been a relative bright spot, with SIA's cargo volume rising 9.4% year-on-year in September 2026. Load factor improved most in the East Asia route region, up 5.3 percentage points to 55.8%. Phillip Securities Research maintains a Neutral stance on the air transport sector amid the lack of near-term stabilisation in the US-Iran conflict. Investment Positives Strong Cargo Growth Driven by AI and Semiconductor Demand Overall cargo volumes held steady in September 2026, but performance diverged sharply by trade lane. Asia-Pacific to US volumes rose 13% to 17% year-on-year, driven by demand for semiconductors and other high-tech goods. South Korea led the growth with volumes up 54% year-on-year, and Singapore posted gains of 26% year-on-year. Singapore's position as a regional processing and re-export hub for artificial intelligence supports its growth, even though it lacks sizeable domestic AI trade production capability. Cargo rates remained elevated. China's Mid-Autumn Festival and National Day Golden Week holidays prompted exporters to rush shipments out before factories closed, which would typically push air freight rates higher. Global spot rates held at US$3.45 per kilogramme, up 33% year-on-year, while Asia-Pacific to US spot rates averaged US$6.75 per kilogramme, up 40% year-on-year. Singapore to US rates were up 62% year-on-year, which supports SIA's cargo yields on US-bound flows. Capacity Expansion into the Fourth Quarter Airlines continue to add international capacity into the fourth quarter of 2026 despite elevated jet fuel prices. Chinese carriers plan to raise international seats by about 9% year-on-year, with available seat kilometres to increase 13%. Long-haul routes to Europe, Russia and Canada are driving the growth. Singapore's fourth-quarter flight capacity is set to rise about 4% year-on-year, driven by the China-Singapore route, where SIA is adding 24% more seats. We believe this could reflect SIA's deepening partnership with Air China to enhance route coordination and revenue sharing. SIA Engineering Benefits from Boeing 777X Certification Delays SIA's largest aircraft backlog is 31 Boeing 777X aircraft, intended to replace the Airbus A380s (12 units, average age 12.7 years) and Boeing 777-300ERs (22 units, average age 16.5 years), the oldest passenger aircraft in the fleet. The 777X is not expected to be delivered before April 2027 because of certification delays, with 665 unfulfilled 777X orders from at least 17 customers. The delays keep these maintenance-heavy aircraft flying longer, supporting near-term demand for SIA Engineering. Furthermore, SIA's largest unit base, the A350XWB (65 units with an average age of 7.5 years), will power SIA Engineering's SAESL joint venture going forward as SAESL expands engine servicing capacity from 300 to 400 engines per annum. SATS Positioned for AI-Driven Airfreight and Middle East Expansion Although e-commerce-driven tailwinds may be weaker, the analyst believes AI-driven airfreight will continue to support SIA's cargo demand. SATS is also expected to expand in the Middle East market alongside Riyadh Air's cargo infrastructure build-out. CAO Special Dividend Potential CAO may benefit from trading margins as regional fuel price differentials have widened. The likelihood of a special dividend or higher payout ratio — currently the lowest among Sinopec subsidiaries, backed by US$589 million in net cash — is identified as the near-term catalyst. Investment Challenges CAO Facing Higher Procurement Costs CAO's decline reflects sustained high jet fuel prices feeding through to cost of sales. With its lower-cost inventory largely used, the benefit from cheaper procurement has faded, and future jet fuel procurement will have to be at current elevated costs. Asia-Europe Cargo Route Remains Weak The Asia-Europe route remained under pressure. Hong Kong to Europe volumes were still down approximately 30% year-on-year as the EU's removal of de minimis exemptions in July 2026 continued to weigh on e-commerce flows. Elevated Jet Fuel Prices Persistently high jet fuel prices remain a headwind for SIA and the broader sector. Singapore jet fuel price normalisation is not expected until 2029. Outlook The sector outlook is mixed. Cargo growth driven by AI and semiconductor demand continues to provide a tailwind, but elevated jet fuel prices and weak Asia-Europe trade lanes present headwinds. SIA's fourth-quarter capacity expansion and deepening partnerships signal cautious optimism, while SIA Engineering benefits from aircraft delivery delays that keep older, maintenance-intensive fleets in operation. Recommendation and Target Price Phillip Securities Research maintains a Neutral sector stance on Singapore air transport. At the individual stock level, SIA carries a Neutral rating with a target price of S$7.09. SATS is rated BUY with a target price of S$5.01. China Aviation Oil is rated BUY with a target price of S$2.01. SIA Engineering is rated BUY with a target price of S$3.90. This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Frequently Asked Questions [market_journal_faq] Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
